TITAN PHARMACEUTICALS CORPORATE PRESENTATION SUNIL BHONSLE JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. NASDAQ:TTNP

First Page		Document Content
Date: 2016-06-20 16:22:04 Neurochemistry Chemistry Drug rehabilitation Morphinans Nervous system Opioid antagonists Euphoriants Alcohols Buprenorphine Opioid use disorder Opioid Methadone		TITAN PHARMACEUTICALS CORPORATE PRESENTATION SUNIL BHONSLE JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. NASDAQ:TTNP Add to Reading List Source URL: c.eqcdn.com Download Document from Source Website File Size: 3,28 MB Share Document on Facebook

	The Opioid Crisis: What You Need to Know The opioid crisis has swept across the nation at an alarming rate. Drug abuse, dependence, and overdose are issues that affect the lives of millions of Americans. Given the sever DocID: 1vrfi - View Document
	Opioid Withdrawal Comfort Pack Order Set Purpose: Certain clinical situations (contract violations, incarceration, etc.) may necessitate abruptly stopping a prescription opioid medication, leading to acute withdrawal. Op DocID: 1vraW - View Document
	APPENDIX 3 SAMPLE OPIOID TREATMENT AGREEMENT Patient Name:_____________________________ Date:___________________ DocID: 1vraO - View Document
	J Ayub Med Coll Abbottabad 2008;A NEW AND NOVEL TREATMENT OF OPIOID DEPENDENCE: NIGELLA SATIVA 500 mg. Sibghatullah Sangi, Shahida P. Ahmed, Muhammad Aslam Channa*, Muhammad Ashfaq†, Shah Murad Mastoi†† DocID: 1vqF5 - View Document
	S.918 passed the General Assembly on May 9, 2018 and was signed by the Governor on May 15, 2018. The law establishes limitations on initial opioid prescriptions for acute pain management or postoperative pain management DocID: 1vnXA - View Document